Safety and Pharmacokinetics of Single and Multiple Ascending Doses of the Novel Oral Human GLP-1 Analogue, Oral Semaglutide, in Healthy Subjects and Subjects with Type 2 Diabetes
This means, it not only optimizes glucose levels and controls cravings, but unlike other injectables, it also boosts energy expenditure
People taking once-daily elecoglipron lost up to 11.8% of their body weight over a 36-week period, the data showed
It involves being able to make smart decisions, knowing how businesses work, knowing your customers, and being strong when things dont go as planned
That said, staying on semaglutide is a decision you should make with your provider based on your health goals, how you respond to treatment, and whether the benefits continue to outweigh any side effects